Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $610.8700 (-0.39%) ($607.2690 - $616.2350) on Thu. Aug. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 54 | Latest Price | $610.8700(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -1.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(45%) SPLV(39%) IVW(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.19% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $627.83 | 5 Day Moving Average | $610.31(0.09%) | 10 Day Moving Average | $621.3(-1.68%) | 20 Day Moving Average | $627.83(-2.7%) | To recent high | -7.2% | To recent low | 12.3% | Market Cap | $64.77b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |